Furthermore, we determined the association of HPC marker expression profiles and HCC malignancy based on serum levels of tumour markers AFP and AFP-L3, and assessed the potential of AFP and AFP-L3 to predict the expression of HPC markers as an alternative non-invasive approach. This evidence concerns the gene AFP and hepatocellular carcinoma.